Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
BPC-157 is one of the most extensively referenced cytoprotective peptides, with studies spanning gastrointestinal, musculoskeletal, cardiovascular, and central nervous system research contexts
Retatrutide, an experimental drug, is only available through an Eli Lilly clinical trial
Consumption of these products has resulted in numerous hospitalizations, [2] and the drugs have been reported to cause hallucinations, increased heartbeat and blood pressure, aggressive behavior, anxiety, muscle spasms, nausea, and vomiting
Safer Handling - Provides a safe,
For subcutaneous versus intramuscular research dosing considerations, see our breakdown on subcutaneous and intramuscular peptide injection, which covers needle gauge and depth recommendations relevant to reconstituted peptide delivery
US$ 22.69
US$ 28.96
US$ 28.81
US$ 27.95
US$ 22.64
